These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31876626)

  • 1. Magnetic Resonance Kidney Parenchyma-T2 as a Novel Imaging Biomarker for Autosomal Dominant Polycystic Kidney Disease.
    Siedek F; Grundmann F; Weiss K; Pinto Dos Santos D; Arjune S; Haneder S; Persigehl T; Müller RU; Baessler B
    Invest Radiol; 2020 Apr; 55(4):217-225. PubMed ID: 31876626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Image texture features predict renal function decline in patients with autosomal dominant polycystic kidney disease.
    Kline TL; Korfiatis P; Edwards ME; Bae KT; Yu A; Chapman AB; Mrug M; Grantham JJ; Landsittel D; Bennett WM; King BF; Harris PC; Torres VE; Erickson BJ;
    Kidney Int; 2017 Nov; 92(5):1206-1216. PubMed ID: 28532709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney Disease.
    Yu ASL; Shen C; Landsittel DP; Harris PC; Torres VE; Mrug M; Bae KT; Grantham JJ; Rahbari-Oskoui FF; Flessner MF; Bennett WM; Chapman AB;
    Kidney Int; 2018 Mar; 93(3):691-699. PubMed ID: 29290310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging Identification of Rapidly Progressing Autosomal Dominant Polycystic Kidney Disease: Simple Eligibility Criterion for Tolvaptan.
    Higashihara E; Horie S; Muto S; Kawano H; Tambo M; Yamaguchi T; Taguchi S; Kaname S; Yokoyama K; Yoshioka T; Furukawa T; Fukuhara H
    Am J Nephrol; 2020; 51(11):881-890. PubMed ID: 33227802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of plasma somatostatin with disease severity and progression in patients with autosomal dominant polycystic kidney disease.
    Messchendorp AL; Spithoven EM; Casteleijn NF; Dam WA; van den Born J; Tonnis WF; Gaillard CAJM; Meijer E;
    BMC Nephrol; 2018 Dec; 19(1):368. PubMed ID: 30567514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spleen phenotype in autosomal dominant polycystic kidney disease.
    Yin X; Prince WK; Blumenfeld JD; Zhang W; Donahue S; Bobb WO; Rennert H; Askin G; Barash I; Prince MR
    Clin Radiol; 2019 Dec; 74(12):975.e17-975.e24. PubMed ID: 31563290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemorrhagic Cysts and Other MR Biomarkers for Predicting Renal Dysfunction Progression in Autosomal Dominant Polycystic Kidney Disease.
    Riyahi S; Dev H; Blumenfeld JD; Rennert H; Yin X; Attari H; Barash I; Chicos I; Bobb W; Donahue S; Prince MR
    J Magn Reson Imaging; 2021 Feb; 53(2):564-576. PubMed ID: 32969110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion magnetic resonance imaging for kidney cyst volume quantification and non-cystic tissue characterisation in ADPKD.
    Caroli A; Villa G; Brambilla P; Trillini M; Sharma K; Sironi S; Remuzzi G; Perico N; Remuzzi A
    Eur Radiol; 2023 Sep; 33(9):6009-6019. PubMed ID: 37017703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T1 vs. T2 weighted magnetic resonance imaging to assess total kidney volume in patients with autosomal dominant polycystic kidney disease.
    van Gastel MDA; Messchendorp AL; Kappert P; Kaatee MA; de Jong M; Renken RJ; Ter Horst GJ; Mahesh SVK; Gansevoort RT;
    Abdom Radiol (NY); 2018 May; 43(5):1215-1222. PubMed ID: 28871393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystatin C estimated glomerular filtration rate to assess renal function in early stages of autosomal dominant polycystic kidney disease.
    Sans L; Radosevic A; Quintian C; Montañés R; Gràcia S; Vilaplana C; Mojal S; Ballarin JA; Fernández-Llama P; Torra R; Pascual J
    PLoS One; 2017; 12(3):e0174583. PubMed ID: 28346513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease.
    Chapman AB; Bost JE; Torres VE; Guay-Woodford L; Bae KT; Landsittel D; Li J; King BF; Martin D; Wetzel LH; Lockhart ME; Harris PC; Moxey-Mims M; Flessner M; Bennett WM; Grantham JJ
    Clin J Am Soc Nephrol; 2012 Mar; 7(3):479-86. PubMed ID: 22344503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of ultrasound and magnetic resonance imaging shows that kidney length predicts chronic kidney disease in autosomal dominant polycystic kidney disease.
    Bhutani H; Smith V; Rahbari-Oskoui F; Mittal A; Grantham JJ; Torres VE; Mrug M; Bae KT; Wu Z; Ge Y; Landslittel D; Gibbs P; O'Neill WC; Chapman AB;
    Kidney Int; 2015 Jul; 88(1):146-51. PubMed ID: 25830764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing Risk of Rapid Progression in Autosomal Dominant Polycystic Kidney Disease and Special Considerations for Disease-Modifying Therapy.
    Chebib FT; Torres VE
    Am J Kidney Dis; 2021 Aug; 78(2):282-292. PubMed ID: 33705818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of arginine vasopressin surrogate marker urinary copeptin with severity of autosomal dominant polycystic kidney disease (ADPKD).
    Nakajima A; Lu Y; Kawano H; Horie S; Muto S
    Clin Exp Nephrol; 2015 Dec; 19(6):1199-205. PubMed ID: 25715868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Severity Model for Pediatric Autosomal Dominant Polycystic Kidney Disease Using 3D Ultrasound Volumetry.
    Breysem L; De Keyzer F; Schellekens P; Dachy A; De Rechter S; Janssens P; Vennekens R; Bammens B; Irazabal MV; Van Ongeval C; Harris PC; Mekahli D;
    Clin J Am Soc Nephrol; 2023 May; 18(5):581-591. PubMed ID: 36800517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Review of the Imaging Techniques for Measuring Kidney and Cyst Volume in Establishing Autosomal Dominant Polycystic Kidney Disease Progression.
    Magistroni R; Corsi C; Martí T; Torra R
    Am J Nephrol; 2018; 48(1):67-78. PubMed ID: 30071518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age- and height-adjusted total kidney volume growth rate in autosomal dominant polycystic kidney diseases.
    Higashihara E; Yamamoto K; Kaname S; Okegawa T; Tanbo M; Yamaguchi T; Shigemori K; Miyazaki I; Yokoyama K; Nutahara K
    Clin Exp Nephrol; 2019 Jan; 23(1):100-111. PubMed ID: 30097754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kidney Energetics and Cyst Burden in Autosomal Dominant Polycystic Kidney Disease: A Pilot Study.
    Bjornstad P; Richard G; Choi YJ; Nowak KL; Steele C; Chonchol MB; Nadeau KJ; Vigers T; Pyle L; Tommerdahl K; van Raalte DH; Hilkin A; Driscoll L; Birznieks C; Hopp K; Wang W; Edelstein C; Nelson RG; Gregory AV; Kline TL; Blondin D; Gitomer B
    Am J Kidney Dis; 2024 Sep; 84(3):286-297.e1. PubMed ID: 38621633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Averaging Measurements From Multiple MRI Pulse Sequences on Kidney Volume Reproducibility in Autosomal Dominant Polycystic Kidney Disease.
    Dev H; Zhu C; Sharbatdaran A; Raza SI; Wang SJ; Romano DJ; Goel A; Teichman K; Moghadam MC; Shih G; Blumenfeld JD; Shimonov D; Chevalier JM; Prince MR
    J Magn Reson Imaging; 2023 Oct; 58(4):1153-1160. PubMed ID: 36645114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The correlation between kidney volume and measured glomerular filtration rate in an Asian ADPKD population: a prospective cohort study.
    Phakdeekitcharoen B; Treesinchai W; Wibulpolprasert P; Boongird S; Klytrayong P
    BMC Nephrol; 2021 May; 22(1):178. PubMed ID: 33992075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.